Search results for " Melanotic"

showing 8 items of 8 documents

Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.

2000

BACKGROUND Making a morphologic distinction between benign and malignant melanocytic tumors of the skin is frequently difficult, especially because “gray zones” between these lesions often exist. DNA image cytometry as an adjuvant method for the diagnosis and prognostic prediction of premalignant lesions and malignant tumors of many other organs is already well established. The aim of this study was to determine whether DNA image cytometry is helpful in distinguishing benign from malignant melanocytic lesions and whether cytometry would give valid information with which to predict the prognoses associated with malignant melanomas. METHODS DNA image cytometry was performed on 127 benign and …

AdultMaleCancer ResearchPathologymedicine.medical_specialtySkin NeoplasmsStatistics as TopicVideo RecordingMalignant transformationBreslow ThicknessHutchinson's Melanotic FreckleNevus BlueNevus Epithelioid and Spindle CellmedicineHumansMelanomaNevusDNA Image CytometryImage CytometryRetrospective StudiesPloidiesbusiness.industryMelanomaCancerReproducibility of ResultsDNA NeoplasmMiddle Agedmedicine.diseaseAneuploidyPrognosisDiploidyHMB-45OncologyEvaluation Studies as TopicImage CytometryMelanocytesFemalebusinessCytometryDysplastic Nevus SyndromePrecancerous ConditionsFollow-Up StudiesForecastingCancer
researchProduct

Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV)

2020

El diagnóstico y tratamiento del melanoma en atención especializada es un campo en el que se han producido numerosos cambios. El objetivo de esta guía es ofrecer a los dermatólogos españoles una referencia para resolver las dudas clínicas más frecuentes basándose en la evidencia actual. Para la realización de esta guía se escogió a miembros del Grupo Español de Dermato-Oncología y Cirugía con experiencia en el tratamiento de estos tumores y con interés en participar en la elaboración de la guía. Se hizo una adaptación de las guías de práctica clínica existentes mediante el método ADAPTE: inicialmente se resumió el proceso de atención y se elaboraron las preguntas clínicas relevantes. Se sel…

Care processmedicine.medical_specialtyPractice guidelineHistologyVenereologySkin NeoplasmsBiopsyTerapéuticaAntineoplastic AgentsDermatologyTherapeutics030204 cardiovascular system & hematologyPathology and Forensic MedicineHutchinson's Melanotic Freckle03 medical and health sciences0302 clinical medicineDiagnòsticDiagnosismedicineRelevance (law)HumansAgree ii030212 general & internal medicineNeoplasm MetastasisMelanomaNeoplasm StagingEvidence-Based Medicinebusiness.industrySentinel Lymph Node BiopsyDiagnósticoDisease ManagementGuidelineDiagnosis Diagnóstico Guía de práctica clínica Melanoma Practice guideline Terapéutica TherapeuticsTerapèuticaPatient preferenceDermatologyCombined Modality TherapyClinical PracticeGuía de práctica clínicaMolecular Diagnostic Techniquesbusiness
researchProduct

Delineating margins of lentigo maligna using a hyperspectral imaging system

2014

Lentigo maligna (LM) is an in situ form of melanoma which can progress into invasive lentigo maligna melanoma (LMM). Variations in the pigmentation and thus visibility of the tumour make assessment of lesion borders challenging. We tested hyperspectral imaging system (HIS) in in vivo preoperative delineation of LM and LMM margins. We compared lesion margins delineated by HIS with those estimated clinically, and confirmed histologically. A total of 14 LMs and 5 LMMs in 19 patients were included. HIS analysis matched the histopathological analysis in 18/19 (94.7%) cases while in 1/19 (5.3%) cases HIS showed lesion extension not confirmed by histopathology (false positives). Compared to clinic…

MalePathologySkin NeoplasmsHyperspectral imaginghyperspectral imagingSURGERYLentigo malignaHutchinson's Melanotic Freckle030207 dermatology & venereal diseases0302 clinical medicinelentigo maligna melanomaImage Processing Computer-AssistedPhotographyMelanomaAged 80 and overtumour margin assessmentMelanomaBiopsy NeedleHyperspectral imagingGeneral MedicineImmunohistochemistry3. Good healthTumour margin assessment030220 oncology & carcinogenesisDisease ProgressionFemaleRadiologylentigo malignamedicine.symptomDiagnostic Imagingmedicine.medical_specialtyDermoscopyDermatologyLentigo malignaSensitivity and SpecificitySampling StudiesDiagnosis DifferentialLesion03 medical and health sciencesMANAGEMENTmedicineHumansCONFOCAL MICROSCOPYALGORITHMLentigo maligna melanomaAgedSKIN-CANCERbusiness.industryLentigo maligna melanomaCAREmedicine.disease3121 General medicine internal medicine and other clinical medicineHistopathologybusiness
researchProduct

Ablative fractional laser-assisted photodynamic therapy for lentigo maligna: a prospective pilot study.

2019

Background Lentigo maligna (LM) is an in‐situ form of melanoma carrying a risk of progression to invasive lentigo maligna melanoma (LMM). LM poses a clinical challenge, with subclinical extension and high recurrence rates after incomplete surgery. Alternative treatment methods have been investigated with varying results. Photodynamic therapy (PDT) with methylaminolaevulinate (MAL) has already proved promising in this respect. Objectives To investigate the efficacy of ablative fractional laser (AFL)‐assisted PDT with 5‐aminolaevulinic acid nanoemulsion (BF‐200 ALA) for treating LM. Methods In this non‐sponsored, prospective pilot study ten histologically verified LMs were treated with AFL‐as…

Malemedicine.medical_specialtyBF-200 ALASkin NeoplasmsBiolääketieteet - Biomedicinemedicine.medical_treatmentFractional laserPhotodynamic therapyPilot ProjectsDermatologyLentigo malignalaserhoitoHutchinson's Melanotic Freckle030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineablative fractional laser5-aminolaevulinic acid nanoemulsionAblative casemedicineHumansmelanoomaProspective StudiesLentigo maligna melanomaSubclinical infectionAgedAged 80 and overbusiness.industryRopivacaineMelanomaSisätaudit - Internal medicineAminolevulinic AcidMiddle Agedmedicine.diseaseCombined Modality Therapy3. Good healthInfectious Diseasesphotodynamic therapyfotodynaaminen hoitoPhotochemotherapy030220 oncology & carcinogenesisFemaleRadiologyLaser Therapylentigo malignabusinessmedicine.drugJournal of the European Academy of Dermatology and Venereology : JEADVReferences
researchProduct

Melanotic neuroectodermal tumour of infancy: a case report and review of the aetiopathogenic hypotheses.

2009

The case of a 2-month-old healthy infant without relevant medical history. The patient was referred due to the aggravation of a swelling occupying the left half of the anterior maxilla. This lesion became visible approximately one month ago; it involved the buccal gingiva and alveolar bone, including the deciduous tooth germs 6.1 and 6.2. The swelling had dimensions of 20 mm x 20 mm. The surgical excision was performed under general anesthesia. The tooth buds of 6.1 and 6.2 were closely related to the tumour and so were removed. The lesion was entirely enucleated. The pathology of the lesion confirmed a melanotic neuroectodermal tumour of infancy. The melanotic neuroectodermal tumour of inf…

Neuroectodermal Tumor MelanoticPathologymedicine.medical_specialtyPopulationAdenoidLesionIncisormedicineHumanseducationGeneral DentistryDental alveolusMaxillary Neoplasmseducation.field_of_studybusiness.industryInfantAnatomy:CIENCIAS MÉDICAS [UNESCO]Neuroepithelial cellBasophilicstomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyMaxillaUNESCO::CIENCIAS MÉDICASSurgerymedicine.symptombusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Correlation of histologic regression in primary melanoma with sentinel node status.

2014

Importance The influence of regression on the status of the sentinel node (SN) is controversial. In many centers, the presence of regression in thin melanomas supports the performance of an SN biopsy. Objective To identify whether regression in primary melanoma has any influence on SN involvement. Design, Setting, and Participants Retrospective study of melanomas with a Breslow thickness greater than 0.75 mm and undergoing SN biopsy from January 1, 2003, through December 31, 2010, at Instituto Valenciano de Oncologia, which receives melanoma patients from regional hospitals and dermatology practices. Only cases with paraffin blocks or histologic slides representative of the primary tumor an…

OncologyAdultMalePathologymedicine.medical_specialtySkin NeoplasmsDermatologyMetastasisBreslow ThicknessHutchinson's Melanotic FreckleStatistical significanceInternal medicineBiopsyMedicineHumansLentigo maligna melanomaMelanomaRetrospective Studiesmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyMelanomaTorsoExtremitiesSentinel nodeMiddle Agedmedicine.diseasePrimary tumorHead and Neck NeoplasmsNeoplasm Regression SpontaneousLymphatic MetastasisFemalebusinessJAMA dermatology
researchProduct

Identification of progenitor cancer stem cell in lentigo maligna melanoma.

2008

:  The potential role of stem cells in neoplasia has aroused considerable interest over the past few years. A number of known biologic characteristics of melanomas support the theory that they may originate in a mutated stem cell. Melanocytic stem cell markers have been described recently. Moreover, the CD133 cells that show surface markers for CD34 are stem cells primitive. These stem cells are capable of differentiating into neurons, glia, keratinocytes, smooth muscle cells, and melanocytes in vitro. The identification of cancer stem/initiating cells with a crucial role in tumor formation may open up new pharmacologic perspectives. The purpose of this study is to detect the expression of …

Pathologymedicine.medical_specialtySkin NeoplasmsCD34Antigens CD34DermatologyBiologyStem cell markerHutchinson's Melanotic FreckleCancer stem cellAntigens CDMelanoblastmedicineSettore MED/35 - Malattie Cutanee E VenereeHumansAC133 AntigenLentigo maligna melanomaGlycoproteinsMelanomaGeneral Medicinemedicine.diseasecancer stem cell lentigo maligna melanomaNeoplastic Stem CellsMelanocytesStem cellPeptidesHair FollicleBiomarkersAdult stem cell
researchProduct

Extrafacial Lentigo Maligna: A Report on 14 Cases and a Review of the Literature

2016

Lentigo maligna is the most common form of in situ melanoma. It is most often found on the head and neck, and its clinical and dermoscopic features in this location have been extensively described in the literature. We present a series of 14 patients diagnosed with extrafacial lentigo maligna and lentigo maligna melanoma at Hospital General de Valencia and Hospital de Manacor in Spain, and describe the clinical, dermoscopic, and histologic features observed. Most of the melanomas were located on the upper limbs; the next most common locations were the trunk and the lower limbs. The dermoscopic patterns were consistent with facial lentigo maligna and superficial spreading melanoma. Extrafaci…

medicine.medical_specialtyHistologybusiness.industryDermatologyLentigo maligna030230 surgeryHutchinson's Melanotic Frecklemedicine.diseaseDermatologyPathology and Forensic MedicineSuperficial spreading melanoma030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineLentigo maligna melanomabusinessHead and neckLentigoActas Dermo-Sifiliográficas (English Edition)
researchProduct